CS, specificafly in extraskeletal myxoid CS. Recently, this translocation has been shown to
represent a rearrangement ofthe EWSgene at 22q12 with a novel gene at 9q22 designated …

Background: Myxoid chondrosarcoma (MCS) is a rare, low-grade, indolent tumor that can
occur in soft tissue and bone. It is, however, capable of distant metastases. Previous …

Skeletal myxoid chondrosarcoma is a histologic variant of conventional skeletal myxoid
chondrosarcoma, whereas extraskeletal myxoid chondrosarcoma is a distinct entity …

BACKGROUND Skeletal myxoid chondrosarcoma (SMC) is considered to be either a typical
chondrosarcoma with prominent myxoid alterations or an altogether unique malignant …

The pathogenesis of myxoid chondrosarcoma (CS) is poorly understood. A recurrent
translocation, t (9; 22)(q22; q12), has been recognized in CS, specifically in extraskeletal …

Extraskeletal myxoid chondrosarcoma is an aggressive tumor with significant metastatic
potential. A 40-year-old man presented with an asymptomatic mass at the left ischial fossa …

Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm with a
characteristic translocation usually involving NR4A3 and EWSR1. EMC has rarely been …

Extraskeletal myxoid chondrosarcoma is a rare soft tissue tumor characterized by a nodular
growth pattern with eosinophilic cells usually in a reticular pattern and abundant myxoid …

BACKGROUND. Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft‐tissue sarcoma
rarely subjected to cytologic analysis. With the exception of a few small series, the cytology …

Introduction Advances in the genetics of soft tissue neoplasia have allowed for the
diagnostic recognition of specific tumor types from small biopsy specimens, including those …